Monday, October 8, 2007

Plenary Session

Moderator:
Kristine Peterson, company group chair, biotechnology, immunology & oncology, Johnson & Johnson

Panelists:

• The Honorable James Greenwood, president and CEO, Biotechnology Industry Organization (BIO)
• The Honorable Billy Tauzin, president and CEO, Pharmaceutical Research and Manufacturers of America (PhRMA)
• Mark Leahey, Esq., executive director, Medical Device Manufacturers Association (MDMA)